Loading...
Chemical structure of Vodobatinib

GC62103

Vodobatinib

Also known as 2-chloro-6-methyl-N'-[4-methyl-3-(2-quinolin-3-ylethynyl)benzoyl]benzohydrazide

Vodobatinib (K0706) is a potent, third generation and orally active Bcr-Abl1 tyrosine kinase inhibitor with an IC50 of 7 nM· Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I· Vodobatinib can be used for chronic myeloid leukemia (CML) research

ChemicalCAS1388803-90-4MW453.92FormulaC27H20ClN3O2
CAS number
1388803-90-4
Molecular weight
453.92
Formula
C27H20ClN3O2
Solubility
DMSO ： 125 mg/mL (275·38 mM; Need ultrasonic)
InChIKey
ZQOBVMHBVWNVBG-UHFFFAOYSA-N
Catalogue number
GC62103
Brand
GLPBIO
Computed properties PubChem CID 89884852 · XLogP 6 · TPSA 71.1 Ų · H-bond donors 2
XLogP
6
TPSA
71.1 Ų
H-bond donors
2
H-bond acceptors
3
Rotatable bonds
4
Heavy atoms
33

SMILES CC1=C(C(=CC=C1)Cl)C(=O)NNC(=O)C2=CC(=C(C=C2)C)C#CC3=CC4=CC=CC=C4N=C3

Computed descriptors from PubChem (CID 89884852), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.